okredo logo
none title certification

Remipharma MB Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

EBITDA margin (%)

Login to see the data

EBIT margin (%)

Login to see the data
Financial report background

Financial statetment report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
Working capital requirementinfo
Debt-to-equity ratioinfo
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2022
9,716
-
-812
-812
-
100.00
-8.36
-712
8,635
697
7,226
2023
57,085
-
27,656
26,261
-
99.81
46.00
25,550
11,717
444
36,823
2024
57,620
-
37,528
35,991
-
93.58
62.46
61,539
5,058
1,531
65,066
unlock data icon

Register and

explore Okredo data
2024
57,620
-
37,528
35,991
-
93.58
62.46
61,539
5,058
1,531
65,066
unlock data icon

Register and

explore Okredo data

2024

Turnover (€)

57,620 €Ascended1 % *

Sales per employee (€)

-

Profit before tax (€)

37,528 €Ascended36 % *

Net Profit (€)

35,991 €Ascended37 % *

Profit per employee (€)

-

Total profitability (%)

93.58 %Descended-6.24 % *

Net profitability (%)

62.46 %Ascended35.78 % *

Equity (€)

61,539 €Ascended141 % *

Amounts Payable And Liabilities (€)

5,058 €Descended-57 % *

Non-current Assets (€)

1,531 €Ascended245 % *

CurrentAssets (€)

65,066 €Ascended77 % *

*over the last year starting selected period